Cite
Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers
MLA
Xiu-Hua Qiu, et al. “Upregulation of Glypican-3 Expression in Hepatocellular Carcinoma but Downregulation in Cholangiocarcinoma Indicates Its Differential Diagnosis Value in Primary Liver Cancers.” Liver International : Official Journal of the International Association for the Study of the Liver, vol. 25, no. 5, Sept. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....37c5bf04a6cd5c2624bb8d6a5f7531c8&authtype=sso&custid=ns315887.
APA
Xiu-Hua Qiu, Hongyang Wang, Bao-Hua Zhang, Xiao-Bo Man, Shen-Jing Li, Liang Tang, & Meng-Chao Wu. (2005). Upregulation of Glypican-3 expression in hepatocellular carcinoma but downregulation in cholangiocarcinoma indicates its differential diagnosis value in primary liver cancers. Liver International : Official Journal of the International Association for the Study of the Liver, 25(5).
Chicago
Xiu-Hua Qiu, Hongyang Wang, Bao-Hua Zhang, Xiao-Bo Man, Shen-Jing Li, Liang Tang, and Meng-Chao Wu. 2005. “Upregulation of Glypican-3 Expression in Hepatocellular Carcinoma but Downregulation in Cholangiocarcinoma Indicates Its Differential Diagnosis Value in Primary Liver Cancers.” Liver International : Official Journal of the International Association for the Study of the Liver 25 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....37c5bf04a6cd5c2624bb8d6a5f7531c8&authtype=sso&custid=ns315887.